Cargando…
Individualized dosing of oral propranolol for treatment of infantile hemangioma: a prospective study
INTRODUCTION: infantile hemangioma is the most common benign tumor in infancy. Currently, oral propranolol is the treatment of choice for infantile hemangioma, but there is no consensus when it comes to its recommended dosage for this condition. Hence this study was conducted to find out the appropr...
Autores principales: | Prasad, Arun, Sinha, Amit Kumar, Kumar, Bindey, Prasad, Abhiranjan, Kumari, Manju |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607273/ https://www.ncbi.nlm.nih.gov/pubmed/31303926 http://dx.doi.org/10.11604/pamj.2019.32.155.16760 |
Ejemplares similares
-
Oral Propranolol in Infantile Hemangiomas: Analysis of Factors that Affect the Outcome
por: Ainipully, Arun Mohanan, et al.
Publicado: (2019) -
Propranolol for treatment of infantile hemangiomas
por: de Melo, Juliana Nakano, et al.
Publicado: (2013) -
Propranolol in the Treatment of Infantile Hemangiomas
por: Tan, Xin, et al.
Publicado: (2021) -
Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012) -
Multiple Infantile Hemangiomas Treated Successfully with Oral Propranolol
por: Purkait, Radheshyam, et al.
Publicado: (2016)